Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | BCHE | P06276 | 4/20 | 0.35 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5138078 | 0.93 | KDM4E (0.43) | HSD11B1KDM4EHSD17B10TSHRC5AR1 | |
| SCHEMBL5136238 | 0.91 | HSD11B1 (0.41) | HSD11B1KDM4EHSD17B10TSHRBCHE | |
| SCHEMBL5135064 | 0.91 | HSD11B1 (0.41) | HSD11B1KDM4EHSD17B10TSHRBCHE | |
| SCHEMBL5075074 | 0.91 | TSHR (0.46) | HSD11B1TSHRBCHEDRD2OPRM1 | |
| SCHEMBL5072355 | 0.90 | HSD11B1 (0.45) | HSD11B1TSHRBCHEC5AR1DRD2 | |
| SCHEMBL5135667 | 0.89 | HSD11B1 (0.44) | HSD11B1TSHRBCHEC5AR1DRD2 | |
| SCHEMBL5134920 | 0.89 | HSD11B1 (0.44) | HSD11B1TSHRBCHEC5AR1DRD2 | |
| SCHEMBL5073933 | 0.87 | HSD11B1 (0.43) | HSD11B1TSHRBCHE | |
| SCHEMBL5135920 | 0.86 | BCHE (0.44) | HSD11B1TSHRBCHE | |
| SCHEMBL5134787 | 0.86 | BCHE (0.42) | HSD11B1TSHRBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |